Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension (UNISUS)
April 23, 2024 updated by: Actelion
A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients With Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg
The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
900
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Study Contact
- Phone Number: 844-434-4210
- Email: Participate-In-This-Study@its.jnj.com
Study Locations
-
-
-
Buenos Aires, Argentina, C1039AAO
- Recruiting
- Sanatorio de la Trinidad Mitre
-
C.a.b.a., Argentina, C1180AAX
- Recruiting
- Sanatorio Güemes
-
Caba, Argentina, 1199ABB
- Recruiting
- Hospital Italiano de Buenos Aires
-
Caba, Argentina, C1048AAN
- Completed
- Sanatorio Ramon Cereijo
-
Caba, Argentina, C1426ABP
- Recruiting
- Centro Médico Dra. De Salvo
-
Corrientes, Argentina, W3400AMZ
- Recruiting
- Instituto de Cardiologia de Corrientes
-
Rosario, Argentina, S2000DSR
- Recruiting
- Instituto Cardiovascular de Rosario
-
Rosario, Argentina, 2000
- Recruiting
- Instituto Médico de la Fundación Estudios Clinicos
-
-
-
-
-
Bedford Park, Australia, 5042
- Recruiting
- Flinders Medical Centre
-
Camperdown, Australia, 2050
- Recruiting
- Royal Prince Alfred Hospital
-
Chermside, Australia, 4032
- Recruiting
- The Prince Charles Hospital
-
Darlinghurst, Australia, 2010
- Recruiting
- St Vincent's Hospital
-
Hobart, Australia, 7000
- Recruiting
- Royal Hobart Hospital
-
Murdoch, Australia, 6150
- Recruiting
- Fiona Stanley Hospital
-
Westmead, Australia, 2145
- Recruiting
- Westmead Hospital
-
-
-
-
-
Graz, Austria, 8036
- Recruiting
- LKH-Univ. Klinikum Graz
-
Linz, Austria, 4020
- Recruiting
- Ordensklinikum Linz GmbH Elisabethinen
-
Vienna, Austria, 1090
- Recruiting
- Medical University Vienna
-
-
-
-
-
Minsk, Belarus, 220036
- Suspended
- The Republican Scientific-Practical Center ''Cardiology''
-
Minsk, Belarus, 220143
- Suspended
- Minsk Regional Clinical Hospital
-
-
-
-
-
Brussels, Belgium, 1070
- Completed
- ULB Hôpital Erasme
-
Leuven, Belgium, 3000
- Recruiting
- UZ Leuven
-
-
-
-
-
Belo Horizonte, Brazil, 30130-100
- Recruiting
- Universidade Federal De Minas Gerais - Hospital das Clínicas
-
Belo Horizonte, Brazil, 30441-070
- Recruiting
- Instituto das Pequenas Missionárias de Maria Imaculada - Hospital Madre Teresa
-
Brasilia, Brazil, 70840-901
- Recruiting
- Empresa Brasileira de Servicos Hospitalares-EBSERH-Hospital Universitario de Brasilia
-
Campina Grande do Sul, Brazil, 83430-000
- Recruiting
- Sociedade Hospitalar Angelina Caron - Hospital Angelina Caron
-
Curitiba, Brazil, 80060-240
- Recruiting
- Ceti - Centro de Estudos Em Terapias Inovadoras
-
Florianopolis, Brazil, 88020-210
- Recruiting
- YNOVA Pesquisa Clinica
-
Goiania, Brazil, 74605-020
- Recruiting
- Universidade Federal de Goias - Hospital das Clinicas da UFG
-
Porto Alegre, Brazil, 90610-000
- Recruiting
- Uniao Brasileira de Educaçao e Assistencia-Hospital Sao Lucas da PUCRS
-
Porto Alegre, Brazil, 90035-003
- Recruiting
- Hospital das Clinicas de Porto Alegre
-
Recife, Brazil, 50070-902
- Recruiting
- Instituto de Medicina Integral Professor Fernando Figueira
-
Santo Andre, Brazil, 09060-870
- Recruiting
- Fundacao do ABC - Centro Universitario FMABC
-
Sao Paulo, Brazil, 05403-000
- Recruiting
- Hospital Das Clinicas Da Faculdade De Medicina Da USP
-
Sao Paulo, Brazil, 04012-909
- Recruiting
- Secretaria de Estado da Saúde - Instituto Dante Pazzanese de Cardiologia
-
-
-
-
-
Sofia, Bulgaria, 1309
- Recruiting
- Multiprofile Hospital For Active Treatment National Cardiology Hospital, Ead
-
Sofia, Bulgaria, 1750
- Recruiting
- University Multiprofile Hospital for Active Treatment- UMHAT Sveta Anna AD
-
-
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 4A6
- Recruiting
- St. Joseph's Health Centre
-
Ottawa, Ontario, Canada, K1Y 4W7
- Recruiting
- University of Ottawa Heart Institute
-
Toronto, Ontario, Canada, M5G2C4
- Recruiting
- University Health Network - Toronto General Hospital
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1E2
- Completed
- Jewish General Hospital
-
-
-
-
-
Beijing, China, 100029
- Recruiting
- Beijing Anzhen Hospital
-
Beijing, China, 100730
- Recruiting
- Peking Union Medical College Hospital
-
Beijing, China, 100020
- Recruiting
- Beijing Chaoyang Hospital
-
Changsha, China, 410011
- Recruiting
- The Second Xiangya Hospital of Central South Hospital
-
Chengdu, China, 610041
- Recruiting
- West China Hospital Sichuan University
-
Chongqing, China, 400016
- Recruiting
- The First Affiliated Hospital of Chongqing Medical University
-
Guangzhou, China, 510120
- Recruiting
- The First Affiliated Hospital of Guangzhou Medical University
-
Shanghai, China, 200433
- Recruiting
- Shanghai Pulmonary Hospital
-
Shanghai, China, 201112
- Recruiting
- Renji Hospital
-
Shanghai, China
- Recruiting
- Zhongshan Hospital Fudan University
-
Shenyang, China, 110004
- Recruiting
- Shengjing Hospital of China Medical University
-
Shenyang, China, 110000
- Recruiting
- The General Hospital of Northern Theater Command
-
Tianjin, China, 300052
- Recruiting
- Tianjin Medical University General Hospital
-
Xi'An, China, 710061
- Recruiting
- The First Affiliated Hospital of Xian Jiaotong University
-
-
-
-
-
Bogota, Colombia, 1101131
- Recruiting
- Fundacion Neumologica Colombiana
-
Bucaramanga - Piedecuesta - Valle De Menzuli, Colombia, 6810002
- Recruiting
- Fundacion Cardiovascular de Colombia
-
Cali, Colombia, 760042
- Recruiting
- Clínica Imbanaco S.A.S.
-
Medellin, Colombia, 681004
- Recruiting
- Centro Cardiovascular Colombiano Clínica Santa María
-
Soledad, Colombia, 0000000
- Recruiting
- Hospital Universidad del Norte
-
-
-
-
-
Praha 2, Czechia, 128 08
- Recruiting
- General University Hospital II.department of Internal Medicine-cardiology and angiology
-
-
-
-
-
Arhus, Denmark, 8200
- Recruiting
- Århus Universitetshospital, Skejby, Hjertemedicinsk Afdeling B
-
-
-
-
-
Brest, France, 29200
- Completed
- CHU de Brest - Hôpital de la Cavale Blanche
-
Caen Cedex, France
- Recruiting
- Hôpital Côte de Nacre
-
Le Kremlin Bicêtre cedex, France, 94270
- Recruiting
- Hopital Bicêtre - Aphp Hôpitaux Universitaires Paris-Sud
-
Lille Cedex, France
- Completed
- CHRU de Lille - Hopital Claude Huriez
-
Marseille Cedex 20, France, 13915
- Completed
- Aphm - Hopital Nord
-
Nice, France, 06001
- Recruiting
- Centre Hospitalier Universitaire - de Nice - Hopital Pasteur
-
St Priest en Jarez Cedex, France, 42277
- Recruiting
- CHU Saint-Etienne - Hopital Nord
-
Toulouse Cedex 9, France
- Recruiting
- Hopital Larrey CHU de Toulouse
-
-
-
-
-
Bad Oeynhausen, Germany, 32545
- Completed
- Ruhr Universitat Bochum Diabeteszentrum
-
Hannover, Germany, 30625
- Recruiting
- Medizinische Hochschule Hannover
-
München, Germany, 81377
- Recruiting
- Medizinische Klinik und Poliklinik V Klinikum Grosshadern der LMU
-
Regensburg, Germany, 93053
- Recruiting
- Universitaetsklinikum Regensburg
-
-
-
-
-
Alexandroupoli, Greece, 681 00
- Recruiting
- University Hospital of Alexandroupolis
-
Athens, Greece, 11528
- Recruiting
- Alexandra General Hospital of Athens
-
Larisa, Greece, 41334
- Recruiting
- University Hospital Of Larissa
-
Thessaloniki, Greece, 54636
- Recruiting
- Ahepa University General Hospital of Thessaloniki
-
-
-
-
-
Budapest, Hungary, 1083
- Recruiting
- Semmelweis Egyetem,Pulmonológiai Klinika
-
Budapest, Hungary, 1096
- Recruiting
- Gottsegen Gyorgy Orszagos Kardiovaszkularis Intezet Felnott kardiologiai osztaly
-
Pecs, Hungary, 7624
- Recruiting
- Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Kar
-
Szeged, Hungary, 6720
- Recruiting
- Szegedi Tudományegyetem, Általános Orvostudományi Kar, Családorvosi Intézet és rendelő
-
-
-
-
-
Ahmedabad, India, 380006
- Recruiting
- NHL Medical College (SVP Hospital IMSR)
-
Ahmedabad, India, 381060
- Recruiting
- Cims Hospital
-
Bangalore, India, 560099
- Recruiting
- Narayana Hrudayalaya Limited
-
Chengalpetu, India, 603203
- Recruiting
- SRM Medical College Hospital & Research Centre
-
Coimbatore, India, 64103
- Recruiting
- Govindaswamy Kuppuswamy Naidu Memorial Hospital
-
Durgapur, India, 713216
- Recruiting
- HealthWorld Hospitals
-
Hyderbad, India, 500034
- Recruiting
- Care Hospitals
-
Kolkata, India, 700099
- Recruiting
- Rabindranath Tagore International Institute of Cardiac Sciences
-
New Delhi, India, 110060
- Recruiting
- Sir Ganga Ram Hospital
-
New Delhi, India, 110002
- Recruiting
- GB Pant Institute of Post Graduate Medical Education & Research
-
Pondicherry, India, 605008
- Recruiting
- Jawaharlal Institute of Postgraduate Medical Education and Research
-
Surat, India, 395001
- Recruiting
- B.D. Mehta Mahavir Heart Institute
-
-
-
-
-
Haifa, Israel, 34362
- Completed
- Carmel Medical Center
-
Jerusalem, Israel, 91031
- Recruiting
- Shaare Zedek Medical Center
-
Rehovot, Israel, 76100
- Recruiting
- Kaplan Medical Center
-
Tel-Hashomer, Israel, 5265601
- Recruiting
- The Chaim Sheba Medical Center
-
Zerifin, Israel, 70300
- Completed
- Yitzhak Shamir Medical Center
-
-
-
-
-
Milano, Italy, 20162
- Recruiting
- ASST Grande Ospedale Metropolitano Niguarda
-
Modena, Italy, 41125
- Recruiting
- AOU Di Modena Policlinico Di Modena
-
Nuoro, Italy, 08100
- Completed
- Ospedale San Francesco
-
Pavia, Italy, 27100
- Recruiting
- Fondazione IRCCS Policlinico San Matteo
-
Pisa, Italy, 56124
- Recruiting
- Fondazione Toscana Gabriele Monasterio CNR
-
Roma, Italy, 00168
- Recruiting
- Policlinico Gemelli Universita Cattolica
-
-
-
-
-
Bunkyo, Japan, 113-8655
- Active, not recruiting
- The University of Tokyo Hospital
-
Fukuoka, Japan, 812 8582
- Active, not recruiting
- Kyushu University Hospital
-
Hiroshima, Japan, 737-8505
- Active, not recruiting
- Kure Kyosai Hospital
-
Kagoshima City, Japan, 890-8544
- Active, not recruiting
- Kagoshima University Hospital
-
Kanagawa, Japan, 216-8511
- Active, not recruiting
- St Marianna University Hospital
-
Kanazawa, Japan, 920-8641
- Completed
- Kanazawa University Hospital
-
Kobe, Japan, 650-0017
- Active, not recruiting
- Kobe University Hospital
-
Kurume, Japan, 830-0011
- Active, not recruiting
- Kurume University Hospital
-
Kyoto, Japan, 606-8507
- Active, not recruiting
- Kyoto University Hospital
-
Kyoto, Japan, 602-8566
- Active, not recruiting
- University Hospital Kyoto Perfectural University of Medicine
-
Matsumoto, Japan, 390-8621
- Active, not recruiting
- Shinshu University Hospital
-
Nagasaki-shi, Japan, 852-8501
- Active, not recruiting
- Nagasaki University Hospital
-
Nagoya, Japan, 466-8560
- Active, not recruiting
- Nagoya University Hospital
-
Nagoya, Japan, 467 8602
- Active, not recruiting
- Nagoya City University Hospital
-
Niigata, Japan, 951 8520
- Active, not recruiting
- Niigata University Medical and Dental Hospital
-
Okayama, Japan, 701-1192
- Active, not recruiting
- National Hospital Organization Okayama Medical Center
-
Okayama, Japan, 700-8558
- Completed
- Okayama University Hospital
-
Sapporo, Japan, 060-8543
- Active, not recruiting
- Sapporo Medical University Hospital
-
Sapporo-shi, Japan, 060-8648
- Active, not recruiting
- Hokkaido University Hospital
-
Suita-Shi, Japan, 564-8565
- Completed
- National Cerebral and Cardiovascular Center
-
Tokyo, Japan, 113-8431
- Active, not recruiting
- Juntendo University Hospital
-
Toyoake, Japan, 470-1192
- Active, not recruiting
- Fujita Health University Hospital
-
Tsukuba-City, Japan, 305-8576
- Active, not recruiting
- University of Tsukuba Hospital
-
-
-
-
-
Seoul, Korea, Republic of, 05505
- Recruiting
- Asan Medical Center
-
Seoul, Korea, Republic of, 06351
- Recruiting
- Samsung Medical Center
-
Seoul, Korea, Republic of, 3080
- Recruiting
- Seoul National University Hospital
-
Seoul, Korea, Republic of, 03722
- Recruiting
- Severance Hospital Yonsei University Health System
-
-
-
-
-
George Town, Malaysia, 10990
- Recruiting
- Hospital Pulau Pinang
-
Kajang, Malaysia, 43000
- Recruiting
- Hospital Serdang
-
Kota Samarahan, Kuching, Malaysia, 94300
- Recruiting
- Sarawak Heart Center
-
Kuala Lumpur, Malaysia, 50400
- Recruiting
- Institut Jantung Negara (National Heart Institute)
-
-
-
-
-
Ciudad De México, Mexico, 14080
- Recruiting
- Instituto Nacional de Cardiologia Dr. Ignacio Chavez
-
Guadalajara, Mexico, 44657
- Recruiting
- Consultorio Privado del Dr. Gabriel Arturo Ramos Lopez
-
Mexico, Mexico, 52787
- Recruiting
- Operadora de Hospitales Angeles SA de CV Hospital Angeles Lomas
-
Monterrey, Mexico, 64718
- Recruiting
- Unidad de Investigacion Clinica en Medicina S.C. (UDICEM)
-
Monterrey, Mexico, 64460
- Recruiting
- Hospital Universitario Dr Jose Eleuterio Gonzalez
-
Morelia, Mexico, 58260
- Recruiting
- Centro de Investigacion Clinica Chapultepec
-
-
-
-
-
Amsterdam, Netherlands, 1081 HV
- Recruiting
- VUMC Amsterdam
-
Nieuwegein, Netherlands, 3435 CM
- Recruiting
- St. Antonius Ziekenhuis Nieuwegein
-
Nijmegen, Netherlands, 6525 GA
- Recruiting
- Radboud Umcn
-
Rotterdam, Netherlands, 3015 CN
- Completed
- Erasmus MC
-
-
-
-
-
Nordbyhagen, Norway, 1478
- Completed
- Akershus Universitetssykehus
-
Oslo, Norway, 372
- Completed
- Oslo University Hospital
-
-
-
-
-
Bialystok, Poland, 15-276
- Recruiting
- Uniwersytecki Szpital Kliniczny w Białymstoku
-
Bydgoszcz, Poland, 85-168
- Completed
- Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy, Klinika Kardiologii
-
Gdansk, Poland, 80214
- Recruiting
- Uniwersyteckie Centrum Kliniczne
-
Katowice, Poland, 40-635
- Recruiting
- SPSK nr 7 SUM w Katowicach Gornoslaskie Centrum Medyczne im. Prof. Leszka Gieca
-
Krakow, Poland, 31-202
- Recruiting
- Krakowski Szpital Specjalityczny im. Jana Pawla II, Oddzial Kliniczny Chorob Serca i Naczyn
-
Szczecin, Poland, 70-111
- Recruiting
- Samodzielny Publiczny Szpital Kliniczny nr 2 PUM
-
Warszawa, Poland, 02-507
- Recruiting
- Centralny Szpital Kliniczny MSWiA w Warszawie
-
Wroclaw, Poland, 51-124
- Completed
- Wojewodzki Szpital Specjalist, Osrodek Badawczo-Rozwojowy
-
-
-
-
-
Coimbra, Portugal, 3004-561
- Recruiting
- Centro Hospitalar e Universitário de Coimbra - Hospitais da Universidade de Coimbra
-
Lisboa, Portugal, 1769-001
- Recruiting
- Centro Hospitalar Lisboa Norte EPE - Hospital Pulido Valente
-
Lisbon, Portugal, 1169-024
- Recruiting
- Hospital De Santa Marta
-
-
-
-
-
Barnaul, Russian Federation, 656055
- Suspended
- Altay Regional Cardiological Dispensary
-
Chelyabinsk, Russian Federation, 454076
- Terminated
- Chelyabinsk Regional Clinical Hospital
-
Kazan, Russian Federation, 420101
- Suspended
- State Autonomous HealthCare Institution 'Interregional Clinical Diagnostic Center'
-
Kemerovo, Russian Federation, 650002
- Terminated
- Scientific and Research Institution of Cardiovascular Diseases Complex Problems
-
Moscow, Russian Federation, 121309
- Completed
- Moscow City Clinical Hospital No.51
-
Moscow, Russian Federation, 121552
- Terminated
- National Medical Research Center of Cardiology of MoH of Russian Federation
-
Saint-Petersburg, Russian Federation, 197341
- Suspended
- National medical Research Center n.a. V.A.Almazov of MoH of Russian Federation
-
Samara, Russian Federation, 443070
- Terminated
- Samara Regional Clinical Cardiological Dispensary
-
Tumen, Russian Federation, 625032
- Completed
- State Autonomous Healthcare Institution of Tyumen Region 'Scientific and Practical Medical Center'
-
Volgograd, Russian Federation, 400008
- Suspended
- Volgograd Regional Clinical Cardiology Center
-
-
-
-
-
Riyadh, Saudi Arabia, 59046
- Recruiting
- King Fahad Medical City
-
Riyadh, Saudi Arabia, 11564
- Recruiting
- King Faisal Specialist Hospital & Research Center
-
-
-
-
-
Belgrade, Serbia, 11000
- Recruiting
- University Clinical Center of Serbia
-
Sremska Kamenica, Serbia, 21204
- Recruiting
- Institute for Pulmonary Disease of Vojvodina
-
-
-
-
-
Singapore, Singapore, 169609
- Recruiting
- National Heart Centre (NHC) Singapore
-
Singapore, Singapore, 119228
- Recruiting
- National University Heart Centre, Singapore
-
-
-
-
-
Bratislava, Slovakia, 833 48
- Recruiting
- Narodny ustav srdcovych a cievnych chorob
-
Kosice, Slovakia, 040 11
- Recruiting
- The Eastern Slovakia Institute of Cardiovascular Diseases
-
-
-
-
-
Johannesburg, South Africa
- Recruiting
- Milpark Hospital
-
Lenasia, South Africa, 1820
- Recruiting
- Dr Kalla
-
-
-
-
-
Barcelona, Spain, 8003
- Completed
- Hosp. Del Mar
-
Barcelona, Spain, 08035
- Completed
- Hosp. Univ. Vall D Hebron
-
Madrid, Spain, 28041
- Recruiting
- Hosp. Univ. 12 de Octubre
-
Madrid, Spain, 28046
- Recruiting
- Hosp. Univ. La Paz
-
Madrid, Spain, 28222
- Recruiting
- Hosp. Univ. Pta. de Hierro Majadahonda
-
Malaga, Spain, 29603
- Recruiting
- Hosp. Costa Del Sol
-
Salamanca, Spain, 37007
- Recruiting
- Hosp. Clinico Univ. de Salamanca
-
-
-
-
-
Goteborg, Sweden, 413 45
- Recruiting
- Sahlgrenska Universitetsjukhuset
-
Lund, Sweden, 221 85
- Completed
- Skanes universitetssjukhus
-
-
-
-
-
Tainan, Taiwan, 704
- Recruiting
- National Cheng Kung University Hospital
-
Taipei, Taiwan, 10002
- Recruiting
- National Taiwan University Hospital
-
Taipei, Taiwan, 10449
- Recruiting
- Mackay Memorial Hospital
-
Taipei, Taiwan, 112
- Recruiting
- Taipei Veterans General Hospital
-
-
-
-
-
Bangkok, Thailand, 10700
- Recruiting
- Siriraj Hospital Mahidol University
-
Bangkok, Thailand, 10400
- Recruiting
- Ramathibodi Hospital, Mahidol University
-
Bangkok, Thailand, 10400
- Completed
- Phramongkutklao Hospital and Medical College
-
Chiang Mai, Thailand, 50020
- Recruiting
- Maharaj Nakorn Chiang Mai hospital - Faculty of Medicine
-
Khon Kaen, Thailand, 40002
- Recruiting
- Srinagarind Hospital, Khon Kaen University
-
Songkhla, Thailand, 90110
- Recruiting
- Songklanagarind Hospital
-
-
-
-
-
Adana, Turkey, 01790
- Completed
- Cukurova University Medical Faculty
-
Adana, Turkey, 01170
- Recruiting
- Adana City Hospital
-
Ankara, Turkey, 06230
- Recruiting
- Hacettepe University Medical Faculty
-
Ankara, Turkey, 06500
- Recruiting
- Gazi University Medical Faculty
-
Ankara, Turkey, 06800
- Recruiting
- Ankara Bilkent Şehir Hastanesi
-
Ankara, Turkey, 06170
- Recruiting
- Ankara Etlik Speciality Hospital
-
Antalya, Turkey, 07059
- Recruiting
- Akdeniz University Medical Faculty
-
Bursa, Turkey, 16310
- Recruiting
- Bursa Yuksek Ihtisas Training and Research Hospital
-
Denizli, Turkey, 20070
- Recruiting
- Pamukkale University Medical Faculty
-
Istanbul, Turkey, 34668
- Recruiting
- Siyami Ersek Training and Research Hospital
-
Istanbul, Turkey, 34899
- Recruiting
- Marmara University Medical Faculty
-
Izmir, Turkey, 35100
- Recruiting
- Ege University Medical Faculty
-
Izmir, Turkey, 35330
- Recruiting
- Dokuz Eylul University Medical Faculty
-
Izmir, Turkey, 35120
- Suspended
- Tepecik Training and Research Hospital
-
Kartal Istanbul, Turkey, 34865
- Recruiting
- Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştirma Hastanesi
-
Mersin, Turkey, 33110
- Recruiting
- Mersin University Medical Faculty
-
-
-
-
-
Cherkassy, Ukraine, 18000
- Suspended
- CNE 'Cherkasy Regional Cardiological Center of Cherkasy Regional Council'
-
Cherkasy, Ukraine, 18009
- Suspended
- Communal Noncommercial Enterprise Cherkasy Regional Hospital of Cherkasy Regional Council
-
Dnipro, Ukraine, 49070
- Suspended
- MI 'Dnipropetrovsk Regional Clinical Center of Cardiology and Cardiac Surgery'
-
Kharkiv, Ukraine, 61176
- Completed
- CNE' City Clinical Hospital #8' of Kharkiv City Council
-
Kyiv, Ukraine, 02000
- Suspended
- SI National Scientific Center Institute of Cardiology of M.D. Strazhesko of NAMS of Ukraine
-
Kyiv, Ukraine, 03680
- Suspended
- State Institute Of Phthisiology And Pulmonology N.A. F.G. Yanovskiy Of Ams Ukraine
-
Lviv, Ukraine, 79010
- Suspended
- Communal Noncommercial Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital'
-
Ternopil, Ukraine, 46002
- Suspended
- Municipal Non-commercial Enterprise Ternopil University Hospital of Ternopil Regional Council
-
-
-
-
-
London, United Kingdom, NW3 2QG
- Recruiting
- Royal Free Hospital
-
Newcastle Upon Tyne, United Kingdom, NE7 7DN
- Recruiting
- Freeman Hospital
-
Sheffield, United Kingdom, S10 2RX
- Recruiting
- Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital
-
-
-
-
Arizona
-
Phoenix, Arizona, United States, 85054
- Recruiting
- Mayo Clinic
-
Phoenix, Arizona, United States, 85012
- Recruiting
- Arizona Pulmonary Specialists, Ltd
-
-
California
-
La Jolla, California, United States, 92037
- Recruiting
- Scripps Memorial Hospital
-
Los Angeles, California, United States, 90033
- Recruiting
- USC Keck
-
Santa Barbara, California, United States, 93105
- Recruiting
- Jeffrey S. Sager, MD Medical Corporation
-
Torrance, California, United States, 90502-2006
- Recruiting
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
-
-
Colorado
-
Denver, Colorado, United States, 80206
- Recruiting
- National Jewish Health
-
-
Florida
-
Weston, Florida, United States, 33331-3609
- Recruiting
- Cleveland Clinic
-
-
Georgia
-
Atlanta, Georgia, United States, 30342
- Recruiting
- Northside Hospital
-
Austell, Georgia, United States, 30106
- Recruiting
- Piedmont Healthcare
-
-
Illinois
-
Oak Lawn, Illinois, United States, 60453
- Completed
- Advocate Christ Medical Center
-
-
Indiana
-
Indianapolis, Indiana, United States, 46260
- Recruiting
- St. Vincent Medical Group, Inc.
-
Indianapolis, Indiana, United States, 46202
- Completed
- Indiana University
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- Recruiting
- University Of Iowa - Hospitals & Clinics
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Recruiting
- Norton Pulmonary Specialists
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70112 7021
- Completed
- Louisiana State University
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-5000
- Recruiting
- University of Michigan
-
Troy, Michigan, United States, 53215
- Recruiting
- Troy Beaumont
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110-1032
- Recruiting
- Washington University School of Medicine
-
Saint Louis, Missouri, United States, 63110
- Recruiting
- Saint Louis University Academic Pavillion
-
-
Nebraska
-
Omaha, Nebraska, United States, 68198-2265
- Recruiting
- University of Nebraska Medical Center
-
-
Nevada
-
Reno, Nevada, United States, 89511
- Recruiting
- Reno Heart Institute
-
-
New York
-
Mineola, New York, United States, 11501
- Completed
- Winthrop University Hospital
-
New York, New York, United States, 10032
- Recruiting
- Columbia University
-
New York, New York, United States, 10029
- Recruiting
- Mount Sinai
-
Stony Brook, New York, United States, 11794
- Completed
- Stony Brook University Medical Center
-
-
North Carolina
-
Durham, North Carolina, United States, 27710-4000
- Recruiting
- Duke
-
-
Ohio
-
Cincinnati, Ohio, United States, 45219
- Recruiting
- Lindner Clinical Trial Center/Christ Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73112
- Recruiting
- Integris Baptist Office
-
-
Oregon
-
Portland, Oregon, United States, 97220-9442
- Recruiting
- The Oregon Clinic
-
Portland, Oregon, United States, 97225-6652
- Recruiting
- Oregon Pulmonary Clinic
-
Portland, Oregon, United States, 97239-3011
- Recruiting
- Oregon Health & Science University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104-5545
- Recruiting
- University of Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15212
- Recruiting
- Allegheny General Hospital of Research
-
Wynnewood, Pennsylvania, United States, 19096
- Completed
- Lankenau Medical Center
-
-
South Carolina
-
Anderson, South Carolina, United States, 29621
- Recruiting
- AnMed Health
-
-
Texas
-
Dallas, Texas, United States, 75390
- Recruiting
- UT Southwestern Medical Center
-
Houston, Texas, United States, 77030-2331
- Recruiting
- Baylor College of Medicine (BCM) - Baylor Heart Clinic
-
Plano, Texas, United States, 75093
- Recruiting
- Baylor Scott White - Plano
-
San Antonio, Texas, United States, 78229-3771
- Recruiting
- San Antonio Methodist/TX Transplant Physicians Group
-
-
Vermont
-
Burlington, Vermont, United States, 05405
- Recruiting
- The Robert Larner, M.D. College of Medicine at The University of Vermont
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- Recruiting
- University of Wisconsin Hospital and Clinics
-
Milwaukee, Wisconsin, United States, 53226
- Recruiting
- Medical College of Wisconsin
-
-
-
-
-
Hanoi, Vietnam
- Recruiting
- Hanoi Medical University Hospital
-
Ho Chi Minh, Vietnam, 700000
- Recruiting
- Tam Anh Hospital
-
Ho Chi Minh, Vietnam, 700000
- Recruiting
- University Medical Center Ho Chi Minh city
-
Ho Chi Minh, Vietnam, 700000
- Recruiting
- Cho Ray Hospital
-
Ho Chi Minh, Vietnam, 700000
- Recruiting
- Tam Duc Heart Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Target population: greater than or equal to (>=) 18 (or the legal age of consent in the jurisdiction in which the study is taking place) years of age
- Target population: Symptomatic Pulmonary Arterial Hypertension (PAH) in World Health Organization Functional Class (WHO FC) II, III, or IV
- Target population: PAH subtype falling in one of the below classifications: Idiopathic; Heritable; Drug- or toxin-induced; Related to: Connective tissue disease, HIV infection, Portal hypertension, and Congenital heart disease with small/coincidental cardiac defect with systemic-to-pulmonary shunt (for example atrial septal defect, ventricular septal defect, patent ductus arteriosus, atrioventricular septal defect) which does not account for the elevated pulmonary vascular resistance (PVR) or persistent PAH documented by an Right heart catheterization (RHC) >= 1 year after simple systemic-to pulmonary shunt repair
- PAH diagnosis confirmed by hemodynamic evaluation at rest at any time prior to screening: Mean pulmonary artery pressure (mPAP) greater than (>) 20 millimeters of mercury (mm Hg), and; Pulmonary artery wedge pressure (PAWP) or left ventricular end diastolic pressure (LVEDP) less than or equal to (<=) 15 mm Hg, and PVR >= 3 Wood Units (that is, >= 240 dyn*sec/cm^5)
- Able to perform the 6-minute walking test (6MWT) with a minimum distance of 50 meters (m) and maximum distance of 440m at screening. Participants able to walk more than 440m at screening are eligible if they are in WHO FC III or IV and n-terminal prohormone of brain natriuretic peptide or n-terminal pro B-type natriuretic peptide (NT-proBNP) level is >=300 nanograms per liter (ng/L) at screening, based on central laboratory results
Exclusion Criteria:
- Known presence of three or more of the following risk factors for heart failure with preserved ejection fraction at screening, based on records that confirm documented medical history: Body mass index (BMI) > 30 kilograms per meter square (kg/m^2), Diabetes mellitus of any type, Essential hypertension (even if well controlled); Coronary artery disease, that is, any of the following: history of stable angina, or known more than 50 percent (%) stenosis in a coronary artery, or history of myocardial infarction, or history of or planned coronary artery bypass grafting and/or coronary artery stenting
- Presence of moderate or severe obstructive lung disease (forced expiratory volume in 1 second [FEV1] / forced vital capacity [FVC] < 70%; and FEV1 < 60% of predicted after bronchodilator administration) ) in participants with a known or suspected history of significant lung disease as documented by a spirometry test performed within 1 year prior to screening
- Known moderate to severe hepatic impairment, defined as Child-Pugh Class B or C, based on records that confirm documented medical history
- Serum aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) > 1.5*upper limit of normal (ULN) at screening
- Hemoglobin < 100 gram per liter (g/L) (< 10 gram per deciliter [g/dL]) at screening
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Macitentan 10 milligrams (mg) + Placebo
Run-in period:Participants who are either endothelin receptor antagonist (ERA)-naïve or who are receiving daily dose of macitentan or ambrisentan less (<) 10 milligrams (mg), or daily dose of bosentan <250 mg, will enter 4-week open-label run-in period with macitentan 10 mg prior to randomization.
ERA-pre-treated participants will bypass run-in period and will be randomized to either macitentan 75 mg or macitentan 10 mg directly.Double-blind Treatment (DBT) Period:Participants will receive macitentan 10 mg orally up to End of DBT.To maintain blind, participants will receive macitentan 37.5 mg-matching placebo for 4 weeks and macitentan 75 mg-matching placebo thereafter up to DBT.Treatment Extension Period:After EDBT, participants will receive macitentan 37.5 mg once a day (qd) orally for 4 weeks, prior to receiving open-label macitentan 75 mg qd orally for 2 years.
To maintain blind, participants will receive macitentan 75 mg-matching placebo during 4-week uptitration.
|
Participants will receive macitentan 10 mg film-coated tablets orally.
Other Names:
Participants will receive macitentan 37.5 mg film-coated tablets orally.
Other Names:
Participants will receive macitentan 75 mg film-coated tablets orally.
Other Names:
Participants will receive matching placebo film-coated tablets orally.
|
|
Experimental: Macitentan 75 mg + Placebo
Run-in period:Participants who are either ERA-naive or who are receiving a daily dose of macitentan or ambrisentan <10 mg, or a daily dose of bosentan <250 mg, will enter 4-week open-label run-in period with macitentan 10 mg prior to randomization.
ERA-pre-treated patients will bypass the run-in period and will be randomized to either macitentan 75 mg or macitentan 10 mg directly.DBT Period: participants will receive macitentan 37.5 mg orally for 4 weeks and macitentan 75 mg thereafter up to End of DBT.
To maintain the blind, participants will receive macitentan 10 mg-matching placebo up to End of DBT.Treatment Extension Period: After EDBT, participants will continue to receive macitentan 75 mg orally for 2 years.
To maintain the blind, participants will receive macitentan 37.5 mg-matching placebo during the 4-week up-titration period.
|
Participants will receive macitentan 10 mg film-coated tablets orally.
Other Names:
Participants will receive macitentan 37.5 mg film-coated tablets orally.
Other Names:
Participants will receive macitentan 75 mg film-coated tablets orally.
Other Names:
Participants will receive matching placebo film-coated tablets orally.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Double-blind Treatment Period: Time to First Clinical Events Committee (CEC)-adjudicated Morbidity or Mortality (M/M) Events
Time Frame: Up to 4 years
|
Time to first CEC-adjudicated M/M event on-treatment (ie.,up to 7 days after last dose of DB study intervention) is defined as time from randomization to first of following events: All-cause death, including death caused by on-treatment adverse event that occur within 4 weeks of study DB treatment discontinuation;non-planned Pulmonary Arterial Hypertension(PAH)-related hospitalization(including for worsening of PAH, atrial septostomy, lung transplantation with or without heart transplantation, or initiation of parenteral prostacyclins);PAH-related disease progression, defined as worsening of World Health Organization(WHO) Functional Class(FC) from baseline or deterioration by at least 15% in exercise capacity, as measured by 6-minute walk distance(6MWD), from baseline and confirmed by second 6MWD test performed on different day within 2 week of initial test or appearance or worsening of signs or symptoms of right-sided heart failure that require initiation of intravenous diuretics.
|
Up to 4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Double-blind Treatment Period: Change From Baseline to Week 24 in 6MWD
Time Frame: Baseline up to Week 24
|
The 6MWT is a non-encouraged test performed to quantify exercise tolerance and capacity.
This standardized test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface.
The goal is for the individual to walk as far as possible in six minutes.
|
Baseline up to Week 24
|
|
Double-blind Treatment Period: Change From Baseline to Week 24 in PAH Symptoms Based on PAH-SYMPACT Questionnaire- Cardiopulmonary Symptom Domain Score
Time Frame: Baseline up to Week 24
|
The Cardiopulmonary Symptoms domain consists of 6 items reported on a 5-point Likert scale (from 0 to 4).
The value 0 means "no symptom" and value 4 corresponds to "very severe symptoms".
The symptoms part of the PAH symptoms and impact questionnaire (PAH-SYMPACT) is completed daily for a 7-day period.
The recall period of symptom items is the last 24 hours.
An average Cardiopulmonary Symptoms domain score is determined based on the daily scores of the 6 items.
|
Baseline up to Week 24
|
|
Double-blind Treatment Period: Change From Baseline to Week 24 in PAH Symptoms Based on PAH-SYMPACT Questionnaire- Cardiovascular Symptom Domain Score
Time Frame: Baseline up to Week 24
|
The Cardiovascular Symptoms domain consists of 5 items reported on a 5-point Likert scale (from 0 to 4).
The value 0 corresponds to "no symptoms" and value 4 corresponds to "very severe symptoms".
The symptoms part of the PAH-SYMPACT is completed daily for a 7 day period.
The recall period of symptom items is the last 24 hours.
An average cardiovascular symptoms domain score is determined based on the daily scores of the 5 items.
|
Baseline up to Week 24
|
|
Double-blind Treatment Period: Time to Death Occurring Between Randomization and End of Double-blind Treatment (EDBT)
Time Frame: Up to 4 years
|
Time to death occurring between randomization and EDBT will be reported.
|
Up to 4 years
|
|
Treatment Extension Period: Time to Death Occurring Between Randomization and End of Study (EOS)
Time Frame: Up to 6 years
|
Time to death occurring between randomization and EOS will be reported.
|
Up to 6 years
|
|
Double-blind Treatment Period: Number of Participants with CEC-adjudicated Death due to PAH and/or Hospitalizations for PAH (First and Recurrent) Events on-treatment
Time Frame: Up to 4 years
|
Number of Participants with CEC-adjudicated death or hospitalization due to PAH will be reported.
|
Up to 4 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Actelion Clinical Trials, Actelion
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 30, 2020
Primary Completion (Estimated)
August 27, 2025
Study Completion (Estimated)
February 20, 2029
Study Registration Dates
First Submitted
January 31, 2020
First Submitted That Met QC Criteria
February 14, 2020
First Posted (Actual)
February 18, 2020
Study Record Updates
Last Update Posted (Actual)
April 24, 2024
Last Update Submitted That Met QC Criteria
April 23, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Hypertension, Pulmonary
- Hypertension
- Pulmonary Arterial Hypertension
- Familial Primary Pulmonary Hypertension
- Molecular Mechanisms of Pharmacological Action
- Endothelin Receptor Antagonists
- Endothelin A Receptor Antagonists
- Endothelin B Receptor Antagonists
- Macitentan
Other Study ID Numbers
- CR108740
- 2019-002533-11 (EudraCT Number)
- AC-055-315 (Other Identifier: Actelion)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The data sharing policy of the Janssen Pharmaceutical Companies of Johnson & Johnson is available at www.janssen.com/clinical-trials/transparency.
As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Arterial Hypertension
-
Vanderbilt University Medical CenterJohns Hopkins UniversityCompletedPulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Associated Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial HypertensionUnited States
-
American Medical Association FoundationWithdrawnIdiopathic Pulmonary Arterial Hypertension.United States
-
Vanderbilt University Medical CenterRecruitingIdiopathic Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial Hypertension | Scleroderma Associated Pulmonary Arterial Hypertension | Appetite Suppressant Associate PAHUnited States
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and DevelopmentUnknown
-
Association de Recherche en Physiopathologie RespiratoireGlaxoSmithKline; Soladis; InterlisUnknownPulmonary Arterial Hypertension (PAH)France
-
Medical University of GrazLudwig Boltzmann Institute for Lung Vascular ResearchCompletedIdiopathic Pulmonary Arterial HypertensionAustria
-
Zhejiang UniversityCompletedIdiopathic Pulmonary Arterial HypertensionChina
-
Gachon University Gil Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National... and other collaboratorsUnknownPulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Deep Phenotyping | Heritable Pulmonary Arterial HypertensionKorea, Republic of
-
Zhejiang UniversityUnknownIdiopathic Pulmonary Arterial HypertensionChina
-
Regina Steringer-MascherbauerUnknownPulmonary Arterial Hypertension WHO Group IAustria
Clinical Trials on Macitentan 10 mg
-
ActelionTerminatedDigital UlcersSpain, United States, Argentina, China, Ireland, Colombia, Israel, New Zealand, Germany, Belgium, Portugal, Netherlands, South Africa, Greece, Mexico, Poland, Puerto Rico, Russian Federation, Turkey, Ukraine, United Kingdom
-
Janssen Research & Development, LLCCompleted
-
ActelionHenry Ford Health System; Covance; Medidata Solutions; Almac Clinical Technologies and other collaboratorsTerminatedCongenital Heart Disease With Fontan CirculationUnited Kingdom, Taiwan, France, Poland, China, Australia, Czechia, Canada, United States, Denmark, New Zealand
-
ActelionCompletedClinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects (RUBATO)Congenital Heart DiseaseUnited States, United Kingdom, Taiwan, Germany, France, Poland, China, Australia, Czechia, Canada, Denmark, New Zealand
-
ActelionCompletedPulmonary Arterial HypertensionChina, Malaysia, United States, Austria, Bulgaria, Chile, France, Germany, Greece, Israel, Mexico, Philippines, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, Turkey, United Kingdom, Vietnam
-
ActelionEPS Corporation; Imepro Inc.; General Laboratory, BML, Inc.; Mitsubishi Logistics...TerminatedChronic Thromboembolic Pulmonary Hypertension (CTEPH)Japan
-
ActelionTerminatedPulmonary Arterial HypertensionChina, Malaysia, United States, Austria, Bulgaria, Chile, France, Germany, Greece, Mexico, Philippines, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, United Kingdom, Vietnam
-
ActelionActive, not recruitingPulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)United States, Japan, Taiwan, Turkey, Canada, China, Germany, Spain, Italy, Malaysia, Hungary, Russian Federation, Brazil, Australia, Bulgaria, Czechia, Mexico, Poland, South Africa
-
ActelionChiltern International Ltd.; Medidata Solutions; Frontier Science & Technology... and other collaboratorsTerminatedHeart Failure With Preserved Ejection Fraction and Pulmonary Vascular DiseaseUnited States, United Kingdom, Israel, Austria, Russian Federation, Germany, Poland, Denmark, Argentina, Brazil, Bulgaria, France, Hungary, Romania, Sweden